New Key Statistics Module, Z-Score and F-Score
TSXV:NGMD Key Ratios
Market Cap C$ M | 22.86 |
Enterprise Value C$ M | 30.93 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 52.50 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | -- |
EPS (TTM) C$ | -0.03 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -5.31 |
EV-to-EBITDA | -5.82 |
PEG | -- |
Shares Outstanding M | 217.73 |
Net Margin (%) | -2,200.00 |
Operating Margin % | -1,856.20 |
Pre-tax Margin (%) | -2,192.22 |
Quick Ratio | 0.17 |
Current Ratio | 0.42 |
ROA % (ttm) | -109.14 |
ROE % (ttm) | -- |
ROIC % (ttm) | -86.97 |
Dividend Yield % | -- |
Altman Z-Score | -9.31 |
TSXV:NGMD Number of Guru Trades
TSXV:NGMD Volume of Guru Trades
Gurus Latest Trades with TSXV:NGMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSXV:NGMD is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NuGen Medical Devices Inc Insider Transactions
No Available Data